Diabetes and cardiometabolic companies often know who they need to sell to but get stuck on execution – the channels, commercial motion, onboarding, and cross-functional coordination. We turn the plan into an operating go-to-market engine that delivers enrolled patients and closed deals.
The Problem
The strategy is in place, but the machine needed to run it is not
Many cardiometabolic companies have decided their buyer and positioning but have no functioning engine – no built channels, no commercial motion, no onboarding flow – to execute it. The plan sits in a deck while nothing moves. Go-to-market execution is about building and running the machine, and that gap is where launches quietly die.
A launch requires marketing, sales, clinical, and ops to move in sync
Bringing a cardiometabolic offering to market touches marketing, sales, clinical, eligibility, and onboarding at once, and if those functions are not coordinated the launch stalls at the seams. A great campaign fails if onboarding is not ready; a great sales motion fails if eligibility breaks. Cross-functional coordination is the actual work of go-to-market, not an afterthought.
The commercial motion remains undefined beyond the first conversation
Companies often launch without a defined path from interest to closed relationship – who follows up, what the stages are, how a payer or patient actually gets to yes. Without that motion, early interest generated at launch leaks away. Building the repeatable commercial motion is what turns a launch moment into sustained revenue.
Onboarding and activation are handled as post-launch cleanup
In this category, a patient or client who signs up but never activates produces no outcome and no retention, yet onboarding is often left as a problem for later. Launching acquisition without a working activation path means the demand converts into churn. Onboarding has to be built as part of go-to-market, not bolted on after the launch.
How We Support You
We begin by translating the strategy into an execution plan with owners, sequencing, and readiness criteria – what must be true across marketing, sales, clinical, and onboarding before launch – grounding the [growth strategy](/services/strategy/) in something the team can actually operate. This bridges the gap between an agreed plan and a functioning engine.
We establish the channels and commercial motion. Through our [marketing](/services/marketing/) practice, we build the acquisition or pipeline channels required by the selected buyer and define a repeatable commercial motion – stages, ownership, and the path to yes – so launch interest converts rather than leaking away.
Through our [product](/services/product/) practice, we make onboarding and activation part of go-to-market so patients or clients who sign up actually activate. Building the activation path ahead of launch prevents demand from turning into immediate churn in a category where activation determines every outcome.
We manage the cross-functional coordination that successful launches require. Marketing, sales, clinical, eligibility, and ops are aligned around one sequence and clear readiness gates, preventing the launch from stalling between functions. This coordination is the real work, and we own it throughout the launch.
From day one, our [measurement](/services/measurement/) practice instruments the engine by connecting launch activity to enrolled patients or closed deals, helping the team learn quickly and refine the motion. A launch begins a commercial engine, and it must be measured accordingly.
We do not hand over a launch plan and leave you to it. We build and operate the go-to-market machine until it generates real commercial results.
What we deliver
- An execution plan with owners, sequence, and cross-functional readiness gates
- Built acquisition or pipeline channels for the chosen buyer
- A defined, repeatable commercial motion with a clear path to yes
- An onboarding and activation path built as part of the launch
- Cross-functional coordination across marketing, sales, clinical, and ops
- Measurement tying launch activity to enrolled patients or closed deals
In diabetes and cardiometabolic health, most launches break down in execution rather than strategy – the buyer and positioning are set, but no one has built the channels, commercial motion, or activation path, or aligned the functions that need to move together, leaving the plan to die in the deck.
Our Methodology
Our 90-day sprint transforms an agreed strategy into an operating go-to-market engine. Days 1-30 center on the execution plan: we convert the strategy into owners, sequencing, and readiness gates across marketing, sales, clinical, and onboarding, while identifying what must be built before launch. This phase concludes with an actionable plan, not a restatement of strategy.
Days 31-60 are focused on building the machine. We establish the channels and commercial motion, create the onboarding and activation path, and coordinate the functions that need to move together. Everything is built against a launch-readiness standard instead of being loosely assembled.
Days 61-90 cover launch, operation, and handoff. We execute the launch, manage cross-functional coordination, connect activity to enrolled patients or closed deals, tune the motion using real signals, and document the operating model for your team to run. Since go-to-market is an ongoing engine, the sprint leaves you with both a functioning machine and the knowledge to operate it.
Our Working Approach
During the first 30 days, we collaborate with leaders in marketing, sales, clinical, and operations because go-to-market execution is inherently cross-functional and requires owners within every function. Expect working sessions focused on sequencing, readiness gates, and what needs to be built.
Days 30-60 shift into the build. Instead of continuing to refine strategy, we establish channels, define the commercial motion, create the activation path, and align the functions around a launch-readiness standard.
Days 60-90 focus on launch and handoff. We operate the launch and its cross-functional coordination, connect activity to real commercial outcomes, refine the motion, and transfer the operating model. Because the engine must continue running beyond launch, most engagements extend for several months so the motion can prove itself after the launch moment.
The team consists of a GTM operator who owns the execution plan and coordination, marketing and product resources that build channels and activation, and a measurement resource connecting the launch to commercial outcomes.
- A decided strategy turned into a running engine
- Built channels and a repeatable commercial motion
- An activation path that converts demand into retained customers
- Functions coordinated so the launch does not stall at the seams
- Launch activity tied to enrolled patients or closed deals
If your diabetes & cardiometabolic health company needs go-to-market leadership, we should talk.
Expand your marketing team output with our experts
Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.
Frequently asked questions
What is the cost of a go-to-market engagement for a diabetes or cardiometabolic company?
Go-to-market execution generally costs $20K-$45K/month throughout the build and launch period, depending on the number of channels and functions in scope, excluding media spend. Pricing is based on the depth of the build and cross-functional coordination, not a fixed number of deliverables. Since we operate the engine toward real commercial outcomes, the investment is evaluated against enrolled patients or closed deals rather than a launch event.
What is the difference between go-to-market execution and GTM strategy?
GTM strategy determines the upstream choices – the buyer, motion, positioning, and pricing – whereas go-to-market execution creates and operates the machine that acts on those choices. Execution is where channels are established, the commercial motion is defined, onboarding is built, and functions are aligned. Strategy defines the bets; execution turns them into reality.
Why do cardiometabolic launches so often get stuck during execution?
The buyer and positioning may be decided, but no one has built the channels, commercial motion, or activation path, and the functions that need to move together remain uncoordinated. Even a great campaign fails when onboarding is not ready, while a strong sales motion fails when eligibility breaks. Go-to-market execution owns precisely that buildout and coordination.
How do you manage the cross-functional coordination required for a launch?
We bring marketing, sales, clinical, eligibility, and ops into one sequence with clear readiness gates, then own coordination throughout the launch so it does not stall between functions. Every function understands what must be true before moving to the next step. This coordination is the core work of go-to-market, and we actively manage it instead of leaving it to chance.
How do you ensure a launch delivers retained customers instead of churn?
We treat the onboarding and activation path as part of go-to-market rather than post-launch cleanup, ensuring that patients or clients who sign up actually activate. Activation drives every outcome in this category, so launching acquisition without a functioning activation path simply turns demand into churn. We track enrollment and retention to tune the engine for lasting results.
What does the process of getting started with go-to-market involve?
We begin by converting your agreed strategy into an execution plan with owners, sequencing, and readiness gates across every function, while identifying everything that must be built before launch. The result is an actionable plan, not a strategy restatement. If your diabetes or cardiometabolic company has a go-to-market plan trapped in a deck, we should discuss putting it into action.
